Age-Related Macular Degeneration

2 competing products in clinical development for Age-Related Macular Degeneration.

Pipeline by Phase

Approved2

All Products (2)

ProductCompanyStageStatusHype
FYB203 2 mg (0.05 mL of 40 mg/mL)Formycon AGApprovedCompleted
77
FYB201 0.5 mg (0.05 mL of 10 mg/mL)Formycon AGApprovedCompleted
77